MX338480B - Ingenol mebutato cristalino. - Google Patents
Ingenol mebutato cristalino.Info
- Publication number
- MX338480B MX338480B MX2012011844A MX2012011844A MX338480B MX 338480 B MX338480 B MX 338480B MX 2012011844 A MX2012011844 A MX 2012011844A MX 2012011844 A MX2012011844 A MX 2012011844A MX 338480 B MX338480 B MX 338480B
- Authority
- MX
- Mexico
- Prior art keywords
- ingenol mebutate
- ingenol
- crystalline form
- relates
- mebutate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/48—Separation; Purification; Stabilisation; Use of additives
- C07C67/52—Separation; Purification; Stabilisation; Use of additives by change in the physical state, e.g. crystallisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
- C07C69/533—Monocarboxylic acid esters having only one carbon-to-carbon double bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/86—Ring systems containing bridged rings containing four rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Crystallography & Structural Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Liquid Crystal Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención se refiere a una nueva forma cristalina de ingenol mebutato, método de preparación del mismo, y su uso. Más específicamente, la invención se refiere a la conversión de ingenol mebutato amorfo (ingenol-3-angelato, PEPOO5) a una forma cristalina, la cual fue caracterizada por cristalografía de Rayos X (XRC) de cristal único, espectroscopia infrarroja de transformada de Fourier de reflectancia total atenuada (FTIR-ATR) y Calorimetría de Barrido Diferencial (DSC).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32503210P | 2010-04-16 | 2010-04-16 | |
PCT/IB2011/001277 WO2011128780A1 (en) | 2010-04-16 | 2011-04-18 | Crystalline ingenol mebutate |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2012011844A MX2012011844A (es) | 2012-11-30 |
MX338480B true MX338480B (es) | 2016-04-19 |
Family
ID=44318125
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2012011844A MX338480B (es) | 2010-04-16 | 2011-04-18 | Ingenol mebutato cristalino. |
Country Status (24)
Country | Link |
---|---|
US (2) | US8653133B2 (es) |
EP (1) | EP2558435B1 (es) |
JP (1) | JP2013525300A (es) |
KR (1) | KR20130091647A (es) |
CN (1) | CN102844294A (es) |
AU (1) | AU2011241893B2 (es) |
BR (1) | BR112012026420A2 (es) |
CA (1) | CA2796044A1 (es) |
CY (1) | CY1119394T1 (es) |
DK (1) | DK2558435T3 (es) |
ES (1) | ES2633814T3 (es) |
HR (1) | HRP20171072T1 (es) |
HU (1) | HUE034138T2 (es) |
IL (1) | IL222265A (es) |
LT (1) | LT2558435T (es) |
MX (1) | MX338480B (es) |
NZ (1) | NZ603567A (es) |
PL (1) | PL2558435T3 (es) |
PT (1) | PT2558435T (es) |
RS (1) | RS56337B1 (es) |
RU (1) | RU2572618C2 (es) |
SI (1) | SI2558435T1 (es) |
WO (1) | WO2011128780A1 (es) |
ZA (1) | ZA201207409B (es) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10143638B2 (en) * | 2009-02-13 | 2018-12-04 | Leo Laboratories Limited | Method of treating skin with ingenol mebutate |
JP2013525300A (ja) | 2010-04-16 | 2013-06-20 | レオ ファーマ アクティーゼルスカブ | 結晶性インゲノールメブテート |
PT2595948T (pt) * | 2010-07-20 | 2019-11-12 | Leo Laboratories Ltd | Um método de produção de ingenol-3-angelato |
US9402823B2 (en) | 2010-12-17 | 2016-08-02 | Leo Laboratories Limited | Ingenols for treating seborrheic keratosis |
WO2012176015A1 (en) * | 2011-06-24 | 2012-12-27 | Leo Pharma A/S | Methods for treating uv-damaged skin and scc tumors and for removing tattoos with topical ingenol mebutate |
US20140350101A1 (en) * | 2011-12-12 | 2014-11-27 | Leo Laboratories Limited | Gel compositions |
WO2013088379A1 (en) * | 2011-12-12 | 2013-06-20 | Leo Laboratories Limited | A topical composition comprising an ingenol derivative and a surfactant-cosolvent mixture |
EP2790669A1 (en) | 2011-12-12 | 2014-10-22 | Leo Laboratories Limited | A topical composition comprising an ingenol derivative and an oily solvent |
WO2013110756A1 (en) * | 2012-01-26 | 2013-08-01 | Leo Pharma A/S | Ingenol mebutate in combination with cryotherapy for the treatment of actinic keratosis |
US20130251782A1 (en) * | 2012-03-22 | 2013-09-26 | Leo Laboratories Limited | Topical application of ingenol mebutate with occlusion |
WO2013182688A1 (en) * | 2012-06-08 | 2013-12-12 | Leo Laboratories Limited | A topical gel composition comprising an ingenol derivative and a solvent mixture |
GB201222403D0 (en) * | 2012-12-12 | 2013-01-23 | Leo Lab Ltd | Gel compositions |
WO2014090859A1 (en) * | 2012-12-12 | 2014-06-19 | Leo Laboratories Limited | Gel compositions |
GB201222405D0 (en) * | 2012-12-12 | 2013-01-23 | Leo Lab Ltd | Gel compositions |
GB201222406D0 (en) * | 2012-12-12 | 2013-01-23 | Leo Lab Ltd | Gel compositions |
AU2014100280B4 (en) * | 2014-03-24 | 2015-01-15 | Leo Pharma A/S | A method of treating skin lesions |
US9526714B2 (en) | 2014-03-24 | 2016-12-27 | Leo Laboratories Limited | Method for treating skin lesions with ingenol mebutate |
CN107510651A (zh) * | 2016-06-17 | 2017-12-26 | 王成 | 一种小分子免疫药物的纳米靶向制剂制备及其用途 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPO864097A0 (en) | 1997-08-19 | 1997-09-11 | Peplin Pty Ltd | Anti-cancer compounds |
US20060052951A1 (en) * | 2004-05-07 | 2006-03-09 | Yaffe Michael B | Methods and compositions for cancer treatment relating to BRCA1 BRCT domain recognition of phosphorylated BACH1 |
RU2438689C9 (ru) * | 2005-06-28 | 2012-03-10 | Амазония Фитомедикаментус ЛТДА | Активная фракция экстракта млечного сока растения семейства euphorbiaceae, способ ее получения, композиция на ее основе (варианты) и способ лечения заболеваний, связанных с пролиферацией клеток (варианты) |
CA2629337A1 (en) * | 2005-11-14 | 2007-05-18 | Peplin Research Pty Ltd | Use of angeloyl-substituted ingenanes in combination with other agents to treat cancer |
BRPI0618926A2 (pt) * | 2005-11-25 | 2011-09-13 | Peplin Research Pty Ltd | uso de um composto de ingenol ou um sal farmaceuticamente aceitável do mesmo |
GB0525680D0 (en) | 2005-12-16 | 2006-01-25 | Peplin Ltd | Therapeutic compositions |
CN101742996B (zh) * | 2007-04-30 | 2013-08-21 | Leo实验室有限公司 | 巨大戟二萜醇在制备治疗非癌性皮肤损伤的药物中的用途 |
JP2013525300A (ja) | 2010-04-16 | 2013-06-20 | レオ ファーマ アクティーゼルスカブ | 結晶性インゲノールメブテート |
-
2011
- 2011-04-18 JP JP2013504356A patent/JP2013525300A/ja active Pending
- 2011-04-18 RS RS20170728A patent/RS56337B1/sr unknown
- 2011-04-18 HU HUE11731076A patent/HUE034138T2/en unknown
- 2011-04-18 EP EP11731076.3A patent/EP2558435B1/en not_active Revoked
- 2011-04-18 CA CA2796044A patent/CA2796044A1/en not_active Abandoned
- 2011-04-18 ES ES11731076.3T patent/ES2633814T3/es active Active
- 2011-04-18 KR KR1020127029898A patent/KR20130091647A/ko not_active Application Discontinuation
- 2011-04-18 WO PCT/IB2011/001277 patent/WO2011128780A1/en active Application Filing
- 2011-04-18 RU RU2012148720/04A patent/RU2572618C2/ru active
- 2011-04-18 US US13/088,910 patent/US8653133B2/en active Active
- 2011-04-18 NZ NZ603567A patent/NZ603567A/xx not_active IP Right Cessation
- 2011-04-18 PT PT117310763T patent/PT2558435T/pt unknown
- 2011-04-18 AU AU2011241893A patent/AU2011241893B2/en not_active Ceased
- 2011-04-18 SI SI201131237T patent/SI2558435T1/sl unknown
- 2011-04-18 PL PL11731076T patent/PL2558435T3/pl unknown
- 2011-04-18 MX MX2012011844A patent/MX338480B/es active IP Right Grant
- 2011-04-18 BR BR112012026420A patent/BR112012026420A2/pt not_active Application Discontinuation
- 2011-04-18 CN CN2011800193189A patent/CN102844294A/zh active Pending
- 2011-04-18 LT LTEP11731076.3T patent/LT2558435T/lt unknown
- 2011-04-18 DK DK11731076.3T patent/DK2558435T3/en active
-
2012
- 2012-10-03 ZA ZA2012/07409A patent/ZA201207409B/en unknown
- 2012-10-09 IL IL222265A patent/IL222265A/en active IP Right Grant
-
2014
- 2014-02-17 US US14/182,274 patent/US9440906B2/en active Active
-
2017
- 2017-07-13 HR HRP20171072TT patent/HRP20171072T1/hr unknown
- 2017-07-18 CY CY20171100767T patent/CY1119394T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
AU2011241893B2 (en) | 2014-11-06 |
ZA201207409B (en) | 2014-06-25 |
DK2558435T3 (en) | 2017-08-14 |
ES2633814T3 (es) | 2017-09-25 |
US8653133B2 (en) | 2014-02-18 |
MX2012011844A (es) | 2012-11-30 |
LT2558435T (lt) | 2017-07-25 |
US20110257262A1 (en) | 2011-10-20 |
EP2558435B1 (en) | 2017-06-07 |
PT2558435T (pt) | 2017-07-24 |
WO2011128780A1 (en) | 2011-10-20 |
PL2558435T3 (pl) | 2017-10-31 |
JP2013525300A (ja) | 2013-06-20 |
IL222265A (en) | 2015-04-30 |
KR20130091647A (ko) | 2013-08-19 |
EP2558435A1 (en) | 2013-02-20 |
CA2796044A1 (en) | 2011-10-20 |
NZ603567A (en) | 2013-10-25 |
US20150025265A1 (en) | 2015-01-22 |
HUE034138T2 (en) | 2018-01-29 |
CN102844294A (zh) | 2012-12-26 |
RU2012148720A (ru) | 2014-05-27 |
RS56337B1 (sr) | 2017-12-29 |
AU2011241893A1 (en) | 2012-12-06 |
IL222265A0 (en) | 2012-12-31 |
CY1119394T1 (el) | 2018-02-14 |
BR112012026420A2 (pt) | 2016-08-02 |
RU2572618C2 (ru) | 2016-01-20 |
HRP20171072T1 (hr) | 2017-10-06 |
SI2558435T1 (sl) | 2017-10-30 |
US9440906B2 (en) | 2016-09-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX338480B (es) | Ingenol mebutato cristalino. | |
CR20130071A (es) | Anticuerpos para el receptor del factor de crecimiento epidérmico 3 (her 3) | |
ZA201403880B (en) | Processes fro the conversion of biomass to oxygenated organic compound, apparatus therefore and compositions produced thereby | |
WO2012110489A3 (en) | Novel european prrsv strain | |
EP2557205A4 (en) | PROCESS FOR PREPARING AN EPITACTIC SINGLE CRYSTAL SILICON CARBIDE SUBSTRATE AND EPITACTIC SINGLE CRYSTAL SILICON CARBIDE SUBSTRATE PRODUCED IN THIS METHOD | |
MX2013011257A (es) | Proceso para la preparacion de dronedarona por n-butilacion. | |
WO2014041487A3 (en) | Enzalutamide polymorphic forms and its preparation | |
EA201400093A1 (ru) | Кристаллические частицы, покрытые мицеллами | |
ZA201304962B (en) | Process for the conversion of a carbohydrate-containing feedstock | |
UA113620C2 (xx) | Композиція, що містить аморфну (5-фтор-2-метил-3-хінолін-2-ілметиліндол-1-іл)оцтову кислоту | |
PL2618663T3 (pl) | Zastosowanie kompozycji do zwiększania wydajności roślin użytkowych | |
EP3395812B8 (en) | Crystalline forms and processes for the preparation of condensed azacycles (cannabinoid receptor modulators) | |
EP2216333A3 (en) | Crystalline forms of Dexlansoprazole | |
EA201200740A1 (ru) | Способ пиролиза углеводов | |
WO2014159239A3 (en) | Antibodies against notch 3 | |
WO2017078896A3 (en) | Process for conversion of acyclic c5 compounds to cyclic c5 compounds and catalyst composition for use therein | |
WO2010027848A3 (en) | Forms of lapatinib compounds and processes for the preparation thereof | |
WO2011058524A3 (en) | Crystalline forms of bosentan salts and processes for their preparation | |
WO2017078898A3 (en) | Process for conversion of acyclic c5 compounds to cyclic c5 compounds and catalyst composition for use therein | |
WO2012159981A3 (en) | PROCESS FOR THE PREPARATION OF α-SUBSTITUTED KETONES AND THEIR APPLICATION IN SYNTHESIS OF PHARMACEUTICALLY ACTIVE COMPOUNDS | |
EA201270786A1 (ru) | α-КРИСТАЛЛИЧЕСКАЯ ФОРМА КАРБАБЕНЗПИРИДА | |
HRP20160767T1 (hr) | Postupak za pripremu kristalnog oblika i agomelatina | |
MX2013010001A (es) | Derivados de androstanediol como compuestos reguladores del crecimiento de las plantas. | |
UA68683U (en) | Komarnytskyi's washer | |
WO2013054273A3 (en) | Process for the preparation of agomelatine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |